Rx-To-OTC Switch Consumer Costs Study 'Flawed' - CHPA

A new study finding Rx-to-OTC switches increase out-of-pocket consumer expenses represents a "flawed fundamental analysis" of drug pricing data and ignores the indirect benefits of OTCs and added costs consumers bear for insurance coverage of prescriptions, the Consumer Healthcare Products Association maintains.